Sintilimab in Combination with Stereotactic Body Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Metastatic Non-Small Cell Lung Cancer: The Multicenter SWORD Phase 2 Trial Article Sintilimab in Combination with Stereotactic Body Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Metastatic Non-Small Cell Lung Cancer: The Multicenter SWORD Phase 2 Trial prag.app 2025年3月31日 Authors: Zhu Zhengfei et al. Fudan University Shanghai Cancer Center Translated by: Kong Yuehong Reviewed by: Zhang... Read More Read more about Sintilimab in Combination with Stereotactic Body Radiotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Metastatic Non-Small Cell Lung Cancer: The Multicenter SWORD Phase 2 Trial
